FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lansoprazole from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

SUPPL AP for LANSOPRAZOLE (LANSOPRAZOLE)